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Objectives: The female condom (FC) is an effective strategy against sexually transmitted infections 
(STIs) in susceptible women and men who have sex with men.  FCs are the only female-initiated dual 
protection method that protects against both STIs and unintended pregnancy. As healthcare 
professionals (HCPs) are a key element in the promotion of contraceptive use, it is important to 
examine attitudes toward FCs among this group. Study participants: 15 male and female HCPs aged 
between 22-57 years recruited from sexual and reproductive health settings located in Brighton, 
London, and Glasgow. Sampling method: purposive sampling with targeted advertisements 
(newsletters and bulletins). Study design: face-to-face and telephone interviews with sexual health 
HCPs. Main outcome measure: potential barriers and facilitators to FCs in the UK. Data were 
analysed thematically to identify common views and perspectives. Results: FCs were thought to be 
unacceptable to most women due to stigma, design, negative visual appeal, insertion difficulties and 
lack of familiarity. The perceived unavailability and higher cost of FCs, in comparison to male 
condoms, are major barriers to their use. Conclusions: HCPs are reluctant to promote FCs, often due 
to the perceived social stigma surrounding FCs. Further education and promotion are needed to 
increase acceptability and correct usage. Future research needs to explore strategies to increase the 
acceptability of FCs among women, men who have sex with men and HCPs.    
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Introduction
In the UK, both sexually transmitted infection (STI) and unintended pregnancy rates remain 
relatively high. In 2017, there were 422,147 diagnoses of STIs made in England (1) and an estimated 
862,785 conceptions, of which one-third were reported as unintended (2). Unintended pregnancies 
and STIs represent an estimated economic burden on the UK’s National Health Service (NHS) in 
excess of £620 million per year (3). Heterosexual women remain at a higher risk than men of 
acquiring an STI (4) and by nature assume the sole physical burden of pregnancy (5).
Sexual health promotion is largely focused on the male condom (MC) for STI prevention in 
both men (6) and women (7), and long-acting reversible contraception (LARC) methods in 
preventing unintended pregnancy for women (8). However, LARC methods do not protect against 
STIs (9) and the MC relies on women negotiating correct use with their male partners (10). There is 
therefore a need for a female-initiated dual protection method.
The female condom (FC), also known as an ‘internal condom’ or ‘femidom’, is currently the 
sole female-initiated dual protection method for STI prevention and contraception (11). This barrier 
device is fitted inside the vagina (12) and can be inserted up to eight hours before intercourse using 
one of two flexible rings and covers both internal and external genitalia, proving useful for 
preventing STIs that are spread primarily via skin contact (e.g. human papillomavirus) (11). FCs have 
a lower rate of leakage than MCs (13) and can be used both vaginally and anally, broadening their 
acceptability, in particular for the LGBTQ+ community.
However, the FC remains underutilised (14) and has faced “formidable hurdles owing to 
significant structural and social barriers” (15). These include a lack of FC production and supply, 
higher cost compared to the MC, resistance from male partners, negative press, and minimal 
promotional efforts (11). A descriptive cross-sectional study (16) assessing Ghanaian women aged 
15-49 years demonstrated low FC use, with only 48.4% of the 380 participants aware of FCs. This 
4
underutilisation may be explained by low FC accessibility and partner resistance, highlighting a 
gender power imbalance.  
Possible advantages of the FC over the MC include comfort, enhanced sexual pleasure, lack 
of male responsibility, and the promotion of women’s sexual agency. (17) For example, in a sample 
of urban Indian women, the FC was attributed with increased pleasure, the alleviation of stress 
associated with STI transmission and pregnancy, especially as some male partners were resistant to 
MC use. (17) However, other women disliked FCs due to decreased pleasure. FCs therefore have 
potential, but design modifications may be required to improve the women’s experience with them. 
Healthcare professionals’ perceptions of ICs
Healthcare professionals (HCPs) treat and prevent illness, injury, and physical and mental 
health problems. The term HCP covers a myriad of job roles, including doctors, nurses, sexual health 
advisors, social workers, and psychologists.  Their role has been posited as a “major missing link” in 
the body of  FC research. (15)  HCP’s acceptance and endorsement of particular contraceptive 
methods may be key in service users’ uptake of the method, as demonstrated by Steiner et al., who 
found that having contact with a health professional was the only factor attributed to consistency of 
birth control usage and the reason for starting contraception (18).
Only a handful of studies have investigated HCP’s perceptions of  FCs (15). In a qualitative 
study of 69 semi-structured interviews with HCPs across 5 HIV/STI and pregnancy prevention 
agencies in New York, sites had zero or a very limited supply of FCs and little knowledge of device 
insertion. Several HCPs regarded FCs as aesthetically unappealing and structurally problematic (e.g. 
the inner ring being too hard). HCPs were also unsure as to whether FCs should be targeted for young 
people or more “high risk” groups such as sex workers. Generalising this study to the wider 
population of HCPs and their clients may, however, be problematic as only one US city was sampled, 
with predominantly young low-income black or Hispanic clients at a high risk of HIV/STIs.   
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The present study sought to add to the limited evidence on the topic by exploring UK HCP’s 
perceptions of the FC. Studies have suggested that HCP’s acceptance and endorsement of particular 
contraceptive methods may be key in service users’ uptake of a method. (18) Study aims included 
identifying UK HCP’s perceptions of the FC and their perceived barriers and facilitators to FC uptake. 
To the best of our knowledge, the present study was the first to investigate the perceptions of the FC 
among HCPs in the UK.
Methods
Design
A qualitative approach using semi-structured interviews, conducted between March to July 
2018, and thematic analysis was used to explore the attitudes of HCPs toward FCs.  Ethical approval 
for this study was obtained by the the University of Southampton Ethics committee (ref: 31205).
Recruitment and participants
Purposive sampling was used to recruit participants. Snowball sampling, a type of purposive 
sampling, is a non-probability sampling method whereby existing participants recruit future 
participants from amongst their social or professional networks (19). Snowball sampling has the 
advantage of creating “dynamic moments where unique social knowledge of an interactional quality 
can be fruitfully generated” (20). Inclusion criteria included: UK-based HCPs practising in either a 
sexual or reproductive health setting (e.g. Genitourinary medicine (GUM) clinics, family planning 
clinics etc.) or general practice (e.g. GP surgery). HCPs were excluded if they were not actively 
practising, worked in settings other than sexual and reproductive health or general practice, or were 
based outside of the UK. 
Advertisements were distributed via newsletters and bulletins through three UK based sexual 
health services (Brighton, London, and Glasgow). These advertisements invited potential participants 
to contribute to a 30-minute interview exploring the attitudes and perspectives of HCPs from GUM 
clinics, general practitioners and related sexual health settings towards the FC in order to greater 
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understand potential barriers and facilitators to FC uptake, and the promotion of the FC to service 
users. Potential participants were asked to contact the first author directly via email and forward the 
advert to colleagues working in sexual health. The study advertisement contained an information 
sheet and online link where participants could record their email address to allow for a telephone 
interview to be arranged. Both face-to-face and telephone interviews were used for data collection. 
Telephone interviews were done with participants who were unable to meet in person. 
All participants provided informed consent; verbal consent was also obtained prior to 
interview commencement. The semi-structured interview topic guide (see Table 1) consisted of open-
ended questions to allow for participants’ expression of their attitudes and experiences. Questions 
were based around topics such as the efficacy of the FC, distribution challenges, and HCP FC 
recommendations. Interviews were audio-recorded and the audio files were stored on a password-
protected computer. Recordings were transcribed verbatim by the first author and analysed 
consecutively. Interviews lasted between 10 to 27 minutes. 
Data analysis
The first author (a male postgraduate Health Psychology student) collected and analysed the 
data, using Braun and Clarke’s method of thematic analysis. (21) Each transcript was read and re-
read, coded, and grouped into themes (based on the conceptual similarity of the codes). For example, 
the theme ‘Perceived barriers to FC uptake’ (see Table 2) included the codes ‘availability’, 
‘acceptability’ and ‘cost’ of the FC. Collecting and analysing data continued until theoretical 
saturation was reached, in this case when coding of the fifteenth participant had been completed. To 
ensure consistency of analysis, the themes were discussed with the co-authors, who also reviewed the 
original transcripts. 
Results
Participants were aged between 22-57 years (mean=38, median=37).  Fifteen participants 
took part in the study; 73% of the sample (11) were women and 27% of the sample (4) were men. All 
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participants held professional roles in sexual health or general practice settings including: sexual 
health nurse (4), sexual health advisor (3), speciality doctor in sexual health (3), consultant doctor in 
sexual health (2), trainee GP (2), and sexual health technician (1).  Six interviews were conducted 
face-to-face, with the remaining nine conducted via telephone. Years of professional sexual health 
experience ranged from 1-22 years (mean=8.8, median=10). Participants were based in sexual and 
reproductive health settings in Brighton, London, and Glasgow. 
In total, six themes were identified reflecting barriers and facilitators to FCs: ‘Acceptability’, 
‘Device limitations and insertion difficulties’, ‘Availability’, ‘Cost’, ‘Education and Promotion’, and 
‘HCP Training’. 
Acceptability
Participants were in agreement that FCs are regarded as an unacceptable barrier method for 
STI prevention and contraception and there was general disinterest in FCs: “…the user is just not that 
interested in them…” (age 40, a specialist doctor in sexual health). Some mentioned possible social 
stigma surrounding FCs, where FCs are ‘frowned upon’, making them a less acceptable barrier 
method:
“…it's not exactly the coolest method of contraception, it’s kind of like, frowned upon if you're 
using a female condom…” (age 22, sexual health technician).
One participant suggested that the stigma surrounding FCs may be due to women not wanting 
“to look like they’re ‘up for it’” (age 42, sexual health advisor), adding that women in the UK find 
carrying MCs far more acceptable than carrying FCs. Overall, FCs were perceived as being 
unacceptable to women. 
Device limitations and insertion difficulties
Comments suggested that the FC design restricted uptake, with FC likened to a “rustling 
plastic bag” or a ‘crisp packet”. They were viewed as aesthetically and audibly unpleasant, and 
perceived as potentially “ruining the mood” during a sexual encounter:
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“I suppose they’re [FCs] not very attractive to look at and they’re quite noisy so, you know, 
getting one of those condoms out in the middle of having sex can be a bit of an off-putting experience 
I suppose.” (age 46, assistant sexual health advisor).
Some considered the FC’s external packaging to be larger than the MC, making the product 
less discreet: “…the packets of the female condoms are much larger so you can't really take them out 
discreetly…” (age 37, clinical nurse specialist).
Ease of device insertion was also considered a barrier to FC uptake. For example, when 
compared to MCs, the FC was regarded as “fiddlier” and impractical  “…asking women halfway 
during a sexual act to open a packet and then sort of, fiddle around putting it inside her, they just 
look at you as if you’re completely crazy…” (age 40, a specialist doctor in sexual health). This may 
reduce device effectiveness. If not inserted correctly, the penis could “miss” the FC during 
intercourse and make the device redundant. Additionally, for some populations, such as those lacking 
dexterity, or those intoxicated, difficulty in FC insertion may be too great to warrant it as a viable 
option.
Availability
All participants believed the FC to be far less available than the MC, often remarking having 
rarely seen the device in either commercial or healthcare settings. Three participants stated they had 
never seen an FC in a clinical environment: “…I've never seen anyone using one [FC] in a clinical 
setting.” (age 26, trainee GP). FC availability was perceived to be poor and this was positioned as a 
barrier to uptake.
Cost
Most HCPs perceived FCs to be significantly more expensive to manufacture than MCs: 
“They’re [FCs] more expensive to produce too aren’t they, so that’s probably a factor [in FC 
uptake]” (age 40, speciality doctor in sexual health). Compared to MCs, FCs were thought to be more 
expensive for both consumer and company: “They’re [FCs] just more expensive than male 
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condoms…” (age 57, speciality doctor in sexual health). National MC distribution schemes were 
mentioned as hindering FC uptake; some participants believed that users would prefer to use freely 
available MCs than to buy FCs. Whilst some participants perceived price to hinder FC uptake, this 
was disputed by three participants who argued FC cost was irrelevant to their position as an 
underutilized method and instead suggested that the issue was more related to product demand: 
“Well…no. I don’t think it’s a cost issue, it’s a demand issue.” (age 33, sexual health advisor).
Education and Promotion
Participants believed that educating the public (particularly young people) about FCs would 
act as a stepping stone to greater use of the device: “…one of the main things [to increase FC uptake] 
would be, shorter-term education targeted campaigns towards young people would be quite useful”. 
(age 37, sexual health consultant). Participants highlighted a need to educate women on correct FC 
application: “…actually having somebody demonstrate it, exactly how to put it on and everything…” 
(age 27, trainee GP). A change in healthcare education policy toward the FC was also mentioned, 
such as including the method in Family Planning Association (FPA) leaflets: “…using the FPA 
leaflet that’s got every single type [of contraception] so that you can unpack what’s acceptable for 
them.” (age 33, sexual health advisor), and including FC education in sex and relationships education 
for young people: “…they need to have a sex and relationships education policy, and… include erm, 
more information about female condoms…” (age 42, sexual health advisor). Participants mentioned 
that FCs should be promoted as equal to MCs: “…you've got to talk about a female condom with as 
much enthusiasm and as much know-how...” (age 37, clinical nurse specialist). FC promotional 
methods mentioned included sexual health campaigns, school sex education interventions, charities 
and commercial retailers (such as high street brands), “…in conjunction with somebody like Ann 
Summers, erm, as an adjunct to their parties, and get people on board like that” (age 33, sexual 
health advisor).
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Targeted FC promotion towards specific populations was perceived to facilitate increased 
uptake. Some argued that targeting young people (16-25) would be best as they represent a group at 
risk of STIs. A couple of participants expressed the importance of familiarizing young people with 
the FC towards the beginning of their sexual history and believed that doing so would normalize FCs 
to young people: “…if they know that their friends are using it, …., then they would know “ah other 
people at my age are using it as well” (age 42, sexual health advisor). However, some questioned 
whether young people would want to use the device or be committed to learning correct device 
insertion. Instead, these HCPs suggested that FC promotion would better serve older women with 
more sexual and reproductive experience or women who experience difficulty in condom negotiation 
with male partners.  
HCP training
In general, the FC was perceived to be a somewhat “forgotten method” and participants spoke 
about the importance of “getting the professionals talking about it [FC]”.  Some participants thought 
that “training the trainers” was important to allow HCPs to become comfortable and confident in 
promoting the FC to service users: “I think maybe re-training staff is key so that they’re comfortable 
and confident to give them [FCs] out.” (age 33, sexual health advisor). Two participants suggested 
that the most efficient way to train HCPs on the FC would be to have either ‘education days’ or 
‘refresher sessions’ which involve all staff present on a given day: “...the way to go about that is 
through education days, if you’re going to do it in-service, because you should have all the clinicians 
there at that point.” (age 29, sexual health nurse).  
Not everyone agreed HCP training would increase FC uptake, however. Two participants 
believed HCP FC training to be unnecessary and ineffective at increasing FC promotion to service 
users; “I doubt you'll get much interest in them even though if I'm honest.” (age 48, speciality doctor 




The present study used qualitative interview methods to investigate what HCPs perceived to 
be barriers and facilitators to FC uptake in the UK. Barriers to FC uptake included acceptability, 
device limitations and insertion difficulties, lack of education and public awareness, cost, and 
availability. Facilitators to FC uptake included education, promotion, and HCP training. Overall, 
there were no specific differences in the responses when comparing HCP role, gender, or age. 
Nevertheless, the authors believe that future quantitative studies would be able to explore these 
patterns. 
Participants in the present study believed FC acceptability amongst the general population to 
be low, with women not perceiving the FC as a viable barrier method. Early studies of worldwide FC 
acceptability reported high rates of acceptability ranging from 37% to 96% (22), with later research 
demonstrating the highest acceptability rates in African settings (23, 24) and Asian settings. (25) 
Studies investigating FC acceptability rates in Western populations have been scarce, with the 
majority of evidence coming from FC intervention trials that have found higher post-intervention 
levels of acceptability and actual FC use in heterosexual couples in the United States (26, 27), and 
Spain. (28) However, a large number of HCPs in our study still believed that the FC would be 
unacceptable to women, a factor that might prevent HCPs from even broaching the topic in 
consultations. 
Issues with the FC as a physical device and insertion practices were thought to be another 
major barrier to FC uptake in the UK.  Many HCPs expressed the view that the device was visually 
unaesthetic and audibly off-putting, attitudes that have been reported by participants in actual-use 
randomized trials (29). The FC was also thought to be more difficult to apply than a MC due to issues 
with inserting the device internally. Indeed, some studies have found that the proportion of users 
experiencing FC insertion difficulty is as large as 30-55% (30), leading to inconsistent use (31). 
However, HCPs in the present study suggested that education interventions which include 
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demonstrations might facilitate FC uptake by improving insertion skill. Artz et al., for example, in a 
study that evaluated a STI clinic-based intervention, found that with practice and repeated use, 
difficulty with FC insertion dropped from 25% to 3%. (32) Findings from the present study combined 
with the existing evidence suggest the importance of skills training in overcoming insertion barriers. 
Furthermore, FC availability in the UK remains low, and no widespread distribution schemes 
currently exist. This is in stark contrast to sustained MC distribution schemes, such as the C-Card, in 
which holders are entitled to a range of free MCs from most pharmacies and healthcare clinics (33). 
Researchers have suggested that availability could increase demand considerably (32), yet there have 
been no attempts to increase the supply of the product in the UK. 
Cost and affordability of the FC were also perceived as barriers to FC uptake. Price as a 
barrier to sustained FC use has been cited in almost every article on the FC from a public health 
perspective (14), and the higher price of the FC (compared to the MC) “continues to plague large-
scale national female condom programs” (26, p.123). Even when publicly funded healthcare agencies 
such as the NHS provide free FCs, they are often in much shorter supply than MCs, as was noted by 
HCPs in the present study. Without a regular supply of free FCs, there is unlikely to be a change in 
FC uptake; price and affordability represent enduring issues that threaten the FC as a viable method. 
Despite identifying barriers to FC uptake, HCPs in the present study believed steps can be 
taken to facilitate improved FC attitude and uptake. These included healthcare (e.g. national sexual 
health schemes) and commercial campaigns (e.g. with high street chains such as Ann Summers). 
Sexual health promotion campaigns in Africa have been successful at improving attitudes towards 
FCs. (34)
Simply calling for the promotion of FCs is not enough, however, and it is important to 
consider exactly what is being promoted and who is being targeted. In our study, promotion of the FC 
was often mentioned alongside condom use negotiation as a tool that allows women to assume 
control over their sexual and reproductive health. The FC has been touted as an object of women’s 
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empowerment by many in the field, but this has yet to translate into FC promotional or marketing 
campaigns. (26) Increasing the image of the FC as an important tool for women’s sexual and 
reproductive health could encourage HCPs to promote it as much as it may encourage new users to 
try the device. 
Limitations
There are several limitations to the present study. Firstly, due to high workloads, HCPs 
represent a population that is generally more difficult to recruit and so snowball sampling was used to 
enhance recruitment. Oversampling of a particular network of HCPs may lead to bias based on 
extraneous factors (e.g., local campaigns, political views) and as such we cannot generalize the 
findings from our sample to all HCPs in the UK. 
Another limitation is that telephone interviews also omit some information that adds to the 
contextual detail of an interview, such as participant body language. Finally, female HCPs made up 
the majority of the sample, with a resultant lack of a male HCP perspective on the FC, a research gap 
that has been highlighted as problematic in other studies (35).  
Implications
The present study is the first to explore barriers and facilitators to FC use in the UK from an 
HCP perspective and the findings have several implications for future efforts to improve FC uptake. 
Firstly, findings suggest a need for increased FC education and training interventions for both 
potential users and HCPs. For the user, educational interventions could take place in school/ 
healthcare settings that would include applying FCs on anatomical models to allow users to gain 
confidence in fitting and using the device. For the HCP, education consisting of in-clinic workshops 
and seminars should be implemented to encourage FC promotion behaviour. This may allow HCPs to 
become more confident in promoting the device to service users. 
Lastly, there is a need for quantitative data regarding FC user acceptability in the UK. Data on 
FC acceptability and uptake in the UK are sparse and largely outdated, with the new designs and FC 
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types available. New UK FC data would serve to reignite the conversation surrounding FCs and also 
serve as an evidence base to be included in HCP FC training programmes.
Conclusion
The FC is an important yet underused and under-promoted product in the field of sexual 
health. HCPs are well-positioned to advocate the FC as service users often turn to them for advice on 
contraception and STI prevention decision making. HCP’s knowledge and perceptions of FCs may 
therefore have a significant effect on overall FC uptake. Interventions to improve FC uptake should 
consider the knowledge and skills of the user but prioritise the influence of the HCP; HCPs are likely 
the catalysts to successful FC efforts.  
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Table 1: Interview Topic Guide.
No. Telephone Interview questions
                   
1
2
What is your age, gender, and professional role?
Can you tell me about your professional background and 
work history?
     
3 Can you tell me what you know about the female condom?
                   
4 To what extent do you think that female condoms are 
effective?
5 Who do you believe the female condom should be targeted 
towards?




What are the main challenges to the national distribution of 
female condoms?
What would facilitate a change in policy to offer female 
condoms to protect women against STIs?
Would you recommend the female condom to a client, and 
can you explain the reason for your answer?
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Table 2: Coding Manual for Thematic Analysis.







General knowledge possessed 
about the FC and attitudes, 
beliefs, and perceptions 
towards the FC
“I don’t know an awful lot…”
“Erm, I think it’s quite old fashioned 
and it’s just quite, I don’t know, it’s 






possessed by the HCP 
regarding the effectiveness of 
the FC as a medical device
“I think they’re of similar efficacy as 
the male condom…”
Perceived 
barriers to FC 
uptake
Acceptability The belief that low user 
acceptability acts as a barrier 
to FC uptake 
“…the user is not that interested in 
them”
“…I'll only offer it to people who I 
think would benefit from it, but most 




The beliefs that the FC 
product itself and issues 
applying the product for use 
act as barriers to FC uptake
“the feedback I've got off patients is 
that it's like having sex with a crisp 
packet…”
“I think they find it a lot more fiddly 
than a [male] condom to put on…”
Lack of public 
awareness and 
education
The beliefs that a lack of 
public awareness of the FC 
and a lack of FC education 
programs act as barriers to FC 
uptake
“I'm not sure, I think a lot of women 
have no idea about them, I think that 
there's probably a lack of education 
about them…”
“…in fact I don't think a lot of people 
are aware of them actually.”
Availability The belief that a lack of 
availability acts as a barrier to 
FC uptake 
“they're not very readily available and 
never in my practice have I given them 
to any patient.”
Cost The belief that pricing of the 
FC acts as a barrier to uptake  





Education The perception that FC 
education programmes could 
facilitate an increase in FC 
uptake
“I think erm, from a healthcare 
awareness point of view education 
would be really useful, and actually 
somebody demonstrating it, exactly 
how to put it on and everything like 
that…”
“…so I think they would need, they 
would need education on how to use 
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them and you know, like a, like a male 
condom really…”
Promotion The perception that increased 
FC promotion could facilitate 
uptake
“…so yeah, maybe just more 
promotion in general, yeah, make 
people a bit more aware and then it's 
their choice at the end of the day if 
they want to use them or not isn't it.”
HCP training The perception that specific 
FC training programmes for 
active HCPs could facilitate 
uptake 
“…maybe re-training staff, so they are 
comfortable and confident to give 
them out.”
“Erm, I think, to start off with you 
need to train the trainers, so getting the 
staff onboard, umm, and then I would 
say, umm, that’s something, they can 
they be talking to patients about using 
them more.”
